Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Rise of
+3.85 (+1.24%) Biogen Idec Inc. - [Ticker: BIIB]Chart Biogen Idec Inc.  News Biogen Idec Inc.  Download Historical Prices for Metastock Biogen Idec Inc. and Others  Technical Analysis Biogen Idec Inc.  
Last Trade315.51Last Trade Time2017-11-01 - 19:35:00
Variation+3.85 (+1.24%)Open312.75
Volume1,047,609Average Volume (3m)0
YieldBid / Ask315.47 x 300 - 315.59 x 200
Former Close311.6652 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
Biogen Idec Inc. -  [Ticker: BIIB] chart
Change to Biogen Idec Inc. Interactive Technical Analysis Chart

Last 10 Forum Topics about Biogen Idec Inc.:
No topics about Biogen Idec Inc. [BIIB] have been found, but a search on the Forum for more topics related to Biogen Idec Inc. is advised.

 News about Biogen Idec Inc. [BIIB]:   (ordered by relevance)
Auto-Injectors Market Demand Overview, Growth Innovation, Latest ...  Digital Journal Chronic Lymphocytic Leukemia Therapeutics Market Expected to ...  Digital Journal Multiple Sclerosis Therapeutics Market to Reach US$ 24.4 Billion ...  Medgadget Bleeding Disorders Treatment Market Market Overview Highlighting ...  Digital Journal Biogen Inc. Agrees to Pay $900 Million to Settle Allegations Related ...  Department of Justice Auto-Injectors Market Demand : Mylan, BD, Johnson & Johnson ... Biogen agrees to $900 million drug kickback settlement on eve of trial  Reuters Oncology Biosimilars Market, Oncology Biosimilars Market analysis ...  Digital Journal DOJ Resolves Michael Bawduniak against Biogen Inc. FCA Lawsuit  The National Law Review Benefits  Biogen Biogen CEO Plots A Slow Return To Growth As Revenue Set To ...  Scrip Biogen International  Biogen Biosimilars  Biogen Responsibility  Biogen Environment  Biogen 2021 Year in Review: Our Commitment to Corporate Responsibility  Biogen Autoimmune Treatment Global Market Report 2023  Yahoo Finance Alzheimer's Drug Slows Cognitive Decline in Key Study  The New York Times Global Dementia Drugs Market Size To Worth USD 36.7 Billion By ...  GlobeNewswire Autoimmune Treatment Global Market Report 2023  GlobeNewswire Chronic Lymphocytic Leukemia Therapeutics Market Growth ...  Digital Journal Verastem Oncology Appoints Rob Gagnon to Board of Directors  Business Wire Biogen Drops Idec From Name - WSJ  The Wall Street Journal Biogen Idec: A Great Company, But Not An Alpha Opportunity ...  Seeking Alpha Biogen Stock To See Much Higher Levels After A 38% Rise Yesterday  Forbes Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix  FierceBiotech Some Biogen Idec employees are taking the `disco bus? to work in Cambridge Spinal Muscular Atrophy (SMA) Treatment Market is poised to grow ...  Digital Journal Pricing Strategy For New Anti-Alzheimer's Drug Puts Access ...  Life Science Leader Magazine Biogen Idec and Genentech Tweak Anti-CD20 Alliance to Prevent ...  Genetic Engineering & Biotechnology News Biogen Idec provides coach commuting for suburban workers  The Boston Globe Atara Biotherapeutics Announces Changes to Its Board of Directors  Business Wire Hybrid and vaccine?induced immunity against SAR?CoV?2 in MS ... Trend Innovations Holding, Inc. Appoints Kenneth L. Waggoner as Chief Executive Officer  Yahoo Finance BPGbio Announces Appointments to its Leadership Team to ...  Business Wire Biogen Idec grabs Convergence, neuropathic pain portfolio in $675 ...  FierceBiotech Differential effects of anti-CD20 therapy on CD4 and CD8 T cells ... Canada OKs Biogen Idec drug for treatment of hemophilia B  The Boston Globe Exclusive: Biogen prices hemophilia drug on par with older therapies  Reuters Current and future players in the lupus market  Pharmaceutical Technology Will Biogen Stock Rise After The Recent 6% Fall?  Forbes Oncology Biosimilars Market Detailed In New Research Report ...  Digital Journal Why Biogen's Alzheimer's drug Aduhelm is so controversial  CNBC Biogen Idec Opens New RTP Facility  Business Wire Propionate exerts neuroprotective and neuroregenerative effects in ... Multiple Sclerosis Therapeutics Market Outlook, Opportunities and ...  Digital Journal GV20 Therapeutics Announces Appointment of Three Advisers  Business Wire Aduhelm | ALZFORUM  Alzforum Biogen, MedRhythms team on multiple sclerosis music-based digital ...  FierceBiotech European neurologists expect Biogen Idec's Tecfidera to be ...  The Pharma Letter FDA approves Biogen Idec?s multiple sclerosis drug  The Boston Globe FDA Approves Biogen Idec's ALPROLIX?, the First Hemophilia B ...  Business Wire Biogen to pay Forward Pharma $1.25 billion to protect MS drug  Reuters FDA approves new Biogen MS drug  The Boston Globe UPDATED: Germany gives an initial 'no additional benefit' on ...  FiercePharma Special Report: Biogen Idec and Facet?Following the Money  Genetic Engineering & Biotechnology News Biogen confirms HQ move to Weston - Boston Business Journal  Boston Business Journal Biogen Agrees to Pay $22 Million to Resolve Allegations that it Paid ...  Department of Justice A Complete Study Exploring Vacuum Pumps Market Emerging ...  Digital Journal AstraZeneca, Cephalon, and Biogen Idec to Pay $55.5 Million to ...  PR Newswire Biogen Idec isn't planning on leaving its Weston complex anytime ...  The Business Journals Leon Kircik, MD, FAAD: The Evolving Acne Arsenal  Dermatology Times Samsung Biologics Completes Full Acquisition of Samsung Bioepis  JD Supra An Increase In Investments In The R&D Of Autoimmune Disease ...  GlobeNewswire Steak dinners, sales reps and risky procedures: Inside the big ...  FierceBiotech Wallpaper Market to Witness Huge Growth in Coming Years With ...  Digital Journal Leaders in health, banking elected to join UC Santa Cruz ... Forward Pharma pulls off a $221M IPO with eyes on unseating Biogen  FierceBiotech Biogen Stock Forecast, Price & News (NASDAQ:BIIB)  MarketBeat Gene Network Sciences Announces Drug Development ...  Pharmaceutical Online Cellular and Humoral Immunity to SARS?CoV?2 Infection in Multiple ... Movers & Shakers, March 11 | BioSpace  BioSpace ClearBridge $2 Stock Buy Reaches $480 on Alzheimer's Drug  Bloomberg Carl Icahn Takes On Biogen Idec ... Again  CNBC Biogen Halts Anti-CD40 Ligand Monoclonal Antibody Trials  Pharmaceutical Online Use of Research Tools May Expose Companies to Patent ... Failed ALS study haunts Biogen in lawsuit from unhappy partner  FierceBiotech U.S. judge rules against Perrigo over $1.9 billion Irish tax liability  Reuters Drugs group Perrigo hit with ?1.64bn Irish back tax bill  Financial Times Wood Waste Management And Recycling Market Size Will Observe ...  Digital Journal The price is right for patient-switching on Biogen's new hemophilia ...  FiercePharma Bioverativ: Advancing Hemophilia Treatments (NASDAQ:BIVV)  Seeking Alpha CORRECTED - Biogen reports six new PML cases with Tysabri  Reuters Landos Biopharma Announces Appointment of Fabio Cataldi, MD ...  GlobeNewswire FDA adds warning to Tecfidera label after patient death  The Pharma Letter How Biogen Makes Money: Treatments for Neurological Disorders  Investopedia Biogen expands executive team at spin-out Bioverativ  The Pharma Letter New Long-lasting Multiple Sclerosis Drug Will Come At a Steep Price  Multiple Sclerosis News Today Tysabri: The Model For Facing A Drug Safety Crisis  Forbes FDA Approves Rituximab for Multiple Pediatric Cancers  Medscape Top 15 Drug Launch Superstars  FiercePharma COVID?19 in multiple sclerosis patients: susceptibility, severity risk ... Sanofi to Acquire Biogen Spin-Off in $11.6-Billion Deal  BioPharm International The top 10 best-selling multiple sclerosis drugs of 2013  FiercePharma Ceres Policy Network Business for Innovative Climate and Energy ...  Ceres A Better Interferon?  Multiple Sclerosis Discovery Forum Alkahest Announces Positive Top-line Data From Phase 2 Study In ...  Clinical Leader As Biogen CEO steps down, analysts see challenges ahead  The Boston Globe 2019 Multiple Sclerosis Treatment Market Research Study by Top Industry Players | Teva Pharmaceuticals, Bayer  openPR Biogen's entry into hemophilia market caps a 'long journey' for ...  The Business Journals
For more news about Biogen Idec Inc. click here:
Biogen Idec Inc. News
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2023 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources